Condition: Lipoprotein Disorder · Sponsor: Novartis Pharmaceuticals
The main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Parkway Medical Center | Birmingham, Alabama, United States | — |
| Heart Center Research Llc | Huntsville, Alabama, United States | — |
| Cardiology and Medicine Clinic PA | Little Rock, Arkansas, United States | — |
| National Heart Institute | Beverly Hills, California, United States | — |
| Alliance Clinical | Canoga Park, California, United States | — |
| Excel Medical Clinical Trials LLC | Boca Raton, Florida, United States | — |
| Zenith Clinical Research | Hollywood, Florida, United States | — |
| Jacksonville Center for Clinical Research | Jacksonville, Florida, United States | — |
| Flourish Res Acq LLC North Miami | Miami, Florida, United States | — |
| Inpatient Research Clinical LLC | Miami Lakes, Florida, United States | — |
| Ocala Cardiovascular Research | Ocala, Florida, United States | — |
| SEC Clinical Research | Pensacola, Florida, United States | — |
+ 51 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.